Jiayin Group Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Jiayin Group Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	320	199	279	474	770	795	890
Research and development	28.9	23.2	22.6	31.4	41.7	51	61.1
Selling and marketing	87.1	57.5	103	157	217	262	347
General and administrative	33.1	23.7	25.9	28.1	30.3	30.3	43.3
Operating income	76.8	46.3	67.8	171	188	171	257
Interest income	0.82	1.18
Other non-operating income	3.36	1.03	2.66	6.3	2.09	13.1	9.6
Pre-tax income	81	56.2	91.9	192	218	177	268
Income tax	5.32	16.7	19.7	22.5	34.9	32.7	48.3
Net income to minority interests	-0.08	-0.43	-0.68	0.08	-0.01	-0	-0
Net income	75.8	38.8	74.1	171	183	145	220
EBITDA	79.3	49.8	70.2	173	189	173	267
EPS, basic	0.36	0.18	0.34	0.79	0.85	0.68	1.05
EPS, diluted	0.36	0.18	0.34	0.79	0.85	0.68	1.05
Shares, basic (weighted)	210	216	216	215	214	212	209
Shares, diluted (weighted)	210	216	216	215	214	212	209

Balance sheet

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	17.5	18	28.6	42.2	52.1	74.1	8.84
Short-term investments	10		0	0
Other current assets	13.1	9.39	9.77	68.6	271	51.8	259
Total current assets							990
Property, plant and equipment	5.61	2.98	1.43	2.74	5.68	6.08	190
Lease right-of-use assets			5.57	4	6.99	7.23	4.46
Long-term investments	0.55	13.4	14.2	13.1	14.3	22.2	43.2
Other non-current assets			0.2	0.26	0.32	101	10.9
Total assets	101	80.5	152	438	795	741	1,252
Short-term debt							22.2
Total current liabilities							527
Long-term debt							73.8
Lease liabilities							0.61
Other non-current liabilities							1.84
Total liabilities	207	152	148	258	460	313	618
Total debt							73.8
Paid-in capital	112	125	132	126	127	125	162
Retained earnings	-218	-194	-125	55.8	215	307	498
Treasury stock				-1.34	-4.99	-3.96	-27.1
Other comprehensive income	0.07	-1.96	-2.82	-0.45	-1.44	0.97	1.55
Shareholders' equity	-107	-70.7	4.37	180	336	429	634
Minority interests	0.04	-0.33	-0.33	-0.23	-0.24	-0.23	-0.22
Total equity	-107	-71.1	4.04	180	335	428	634
Total liabilities and equity	101	80.5	152	438	795	741	1,252
Shares outstanding	216

Cash flow statement

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	75.7	38.3	73.4	171	183	145	220
Depreciation and amortization	2.54	3.55	2.46	1.44	1.33	2.45	10.1
Stock-based compensation	21.2	4.7	2.38	6.17	7.66	8.1	22.6
Cash from operations	3.78	-5.44	29	19.4	54.9	195	180
Capital expenditures	-3.97	-0.13	-0.43	-2.53	-4.44	-101	-90.8
Purchases of investments	-10.3
Cash from investing	-33.6	5.09	-19.8	-3.33	-14.9	-107	-278
Stock issued	35	1.07	1.15	0.32	0.18	0.02
Share buybacks				-2.14	-5.36	-7.3	-15.8
Cash from financing	35.1	1.62	1.56	-1.82	-27.3	-45.6	69.7
Exchange rate effect	0.35	-1.71	-0.47	1.51	-1.5	-0.56	-0.11
Net change in cash	5.63	-0.43	10.2	15.7	11.2	41.8	-28.9
Free cash flow	-0.19	-5.57	28.5	16.8	50.4	94	89
Interest paid							0.32
Income taxes paid	7.98	0.03	1.04	0.28	5.76	16.3	4.89

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $1.51 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	28.9%	Operating income / revenue.
EBITDA margin	30.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	30.1%	Pre-tax income / revenue.
Net margin	24.7%	Net income / revenue.
FCF margin	10.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	20.2%	Cash from operations / revenue.
Effective tax rate	18.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	41.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	22.0%	Net income / average total assets.
Return on invested capital (ROIC)	40.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	6.9%	Research and development expense / revenue.
Stock-based pay / revenue	2.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	10.2%	Capital expenditures / revenue.
D&A / revenue	1.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	12.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	23.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	34.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	50.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	14.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	40.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	54.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	15.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	39.9%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	51.7%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	8.7%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	41.5%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	54.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	9.9%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	42.3%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-7.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	110.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y	-5.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	74.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	47.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	52.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	68.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	41.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	73.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.88x	Current assets / current liabilities.
Quick ratio	0.02x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.02x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.12x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	5.9%	Total debt / total assets.
Liabilities / assets	49.4%	Total liabilities / total assets.
Net debt	$64.9M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.24x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$463.1M	Current assets - current liabilities.
Tangible book value	$633.9M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.89x	Revenue / average total assets.
Fixed asset turnover	9.09x	Revenue / average property, plant and equipment.
FCF conversion	40.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	50.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.05	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$1.05	Net income per basic share, as reported (split-adjusted).
Revenue per share	$4.26	Revenue / diluted weighted shares.
FCF per share	$0.43	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.86	Cash from operations / diluted weighted shares.
Book value per share	$3.03	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$3.03	Tangible book value / shares outstanding.
Cash per share	$0.04	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	17.8%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$79.0M	Share price x shares outstanding.
Enterprise value	$144.0M	Market cap + total debt - cash - short-term investments.
P/E	0.36x	Market cap / net income. Only when net income is positive.
P/S	0.09x	Market cap / revenue.
P/B	0.12x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.12x	Market cap / tangible book value, when positive.
P/FCF	0.89x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	0.44x	Market cap / cash from operations, when positive.
EV/Sales	0.16x	Enterprise value / revenue.
EV/EBIT	0.56x	Enterprise value / operating income, when both are positive.
EV/EBITDA	0.54x	Enterprise value / EBITDA, when both are positive.
EV/FCF	1.62x	Enterprise value / free cash flow, when both are positive.
FCF yield	112.6%	Free cash flow / market cap.
Earnings yield	277.9%	Net income / market cap (the inverse of P/E).
Shareholder yield	20.0%	(Dividends paid + share buybacks) / market cap.
PEG	0.04x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Jiayin Group Inc.'s revenue in fiscal 2025?

Jiayin Group Inc. reported revenue of $889.8M for fiscal 2025, 12% higher than the year before.

Was Jiayin Group Inc. profitable in fiscal 2025?

Yes. Net income was $219.6M, a net margin of 24.7%.

How much free cash flow did Jiayin Group Inc. generate in fiscal 2025?

Cash from operations of $179.8M minus capital expenditures of $90.8M left free cash flow of $89.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Jiayin Group Inc.